{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:30:05Z","timestamp":1784752205706,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T00:00:00Z","timestamp":1299283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00296-011-1842-x","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T20:42:06Z","timestamp":1299357726000},"page":"1655-1661","source":"Crossref","is-referenced-by-count":5,"title":["Survival in progressive systemic sclerosis with pulmonary involvement: a single-center experience in Istanbul, Turkey"],"prefix":"10.1007","volume":"32","author":[{"given":"Ferit","family":"zuhur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayid Shafi","family":"Zuhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Zuhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benan","family":"Musellim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Ongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,5]]},"reference":[{"key":"1842_CR1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1179\/acb.2007.049","volume":"62","author":"FE Roufosse","year":"2007","unstructured":"Roufosse FE, de Bellefon LM (2007) Systemic sclerosis. Acta Clin Belg 62:323\u2013329","journal-title":"Acta Clin Belg"},{"key":"1842_CR2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1513\/pats.200608-152MS","volume":"4","author":"RM Du Bois","year":"2007","unstructured":"Du Bois RM (2007) Mechanisms of scleroderma-induced lung disease. Proc Am Thorac Soc 4:434\u2013438","journal-title":"Proc Am Thorac Soc"},{"key":"1842_CR3","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","volume":"165","author":"D Bouros","year":"2002","unstructured":"Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165:1581\u20131586","journal-title":"Am J Respir Crit Care Med"},{"key":"1842_CR4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10067-006-0302-6","volume":"26","author":"M Benan","year":"2007","unstructured":"Benan M, Hande I, Gul O (2007) The natural course of progressive systemic sclerosis patients with interstitial lung involvement. Clin Rheumatol 26:349\u2013354","journal-title":"Clin Rheumatol"},{"key":"1842_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/rheumatology\/keg033","volume":"42","author":"CP Sime\u00f3n","year":"2003","unstructured":"Sime\u00f3n CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M et al (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 42:71\u201375","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1842_CR6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/rheumatology\/37.7.750","volume":"37","author":"S Jacobsen","year":"1998","unstructured":"Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis. Br J Rheumatol 37(7):750\u2013755","journal-title":"Br J Rheumatol"},{"key":"1842_CR7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","volume":"57","author":"R Hesselstrand","year":"1998","unstructured":"Hesselstrand R, Scheja A, Akesson A (1998) Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 57:682\u2013686","journal-title":"Ann Rheum Dis"},{"key":"1842_CR8","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/rheumatology\/35.11.1122","volume":"35","author":"C Bryan","year":"1996","unstructured":"Bryan C, Howard Y, Brennan P, Black C, Silman A (1996) Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br J Rheumatol 35:1122\u20131126","journal-title":"Br J Rheumatol"},{"key":"1842_CR9","first-page":"2100","volume":"22","author":"M Abu-Shakra","year":"1995","unstructured":"Abu-Shakra M, Lee P (1995) Mortality in systemic sclerosis: a comparison with the general population. J Rheumatol 22:2100\u20132102","journal-title":"J Rheumatol"},{"key":"1842_CR10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y","volume":"42","author":"M Kuwana","year":"1999","unstructured":"Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM (1999) Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 42:465\u2013474","journal-title":"Arthritis Rheum"},{"key":"1842_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/art.1780340405","volume":"34","author":"RD Altman","year":"1991","unstructured":"Altman RD, Medsger TA Jr, Bloch DA, Michel BA (1991) Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403\u2013413","journal-title":"Arthritis Rheum"},{"key":"1842_CR12","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246\u20132255","journal-title":"Arthritis Rheum"},{"key":"1842_CR13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66:940\u2013944","journal-title":"Ann Rheum Dis"},{"key":"1842_CR14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"Subcoomittee for Scleroderma Criteria of tht American Rheumatism Association Diagnostic, therapeutic Criteria Committee","year":"1980","unstructured":"Subcoomittee for Scleroderma Criteria of tht American Rheumatism Association Diagnostic, therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis. Arthritis Rheum 23:581\u2013590","journal-title":"Arthritis Rheum"},{"key":"1842_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.semarthrit.2008.06.002","volume":"39","author":"FF Al-Dhaher","year":"2010","unstructured":"Al-Dhaher FF, Pope JE, Ouimet JM (2010) Determinants of morbidity and mortality of systemic Sclerosis in Canada. Semin Arthritis Rheum 39:269\u2013277","journal-title":"Semin Arthritis Rheum"},{"key":"1842_CR16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.semarthrit.2004.09.001","volume":"34","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Tsifetaki N, Voulgari PV, Siozos C, Tsamandouraki K, Alexiou GA et al (2005) Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 34:714\u2013720","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1842_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/ard.30.6.581","volume":"30","author":"R Bennett","year":"1971","unstructured":"Bennett R, Bluestone R, Holt PJ, Bywaters EG (1971) Survival in scleroderma. Ann Rheum Dis 30(6):581\u2013588","journal-title":"Ann Rheum Dis"},{"key":"1842_CR18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1346-8138.1996.tb02680.x","volume":"23","author":"K Nishioka","year":"1996","unstructured":"Nishioka K, Katayama I, Kondo H, Shinkai H, Ueki H, Tamaki K (1996) Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 23:677\u2013682","journal-title":"J Dermatol"},{"key":"1842_CR19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.1780360405","volume":"36","author":"M Abu-Shakra","year":"1993","unstructured":"Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460\u2013464","journal-title":"Arthritis Rheum"},{"key":"1842_CR20","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/35.10.989","volume":"35","author":"ET Koh","year":"1996","unstructured":"Koh ET, Lee P, Gladman DD, Abu-Shakra M (1996) Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 35:989\u2013993","journal-title":"Br J Rheumatol"},{"key":"1842_CR21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.21538","volume":"54","author":"S Trad","year":"2006","unstructured":"Trad S, Amoura Z, Beigelman C, Haroche J, Costedoat N, Boutin le TH (2006) Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 54:184\u2013191","journal-title":"Arthritis Rheum"},{"key":"1842_CR22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/hrt.2005.069484","volume":"92","author":"MH Williams","year":"2006","unstructured":"Williams MH, Das C, Handler CE, Akram MR, Davar J, Denton CP (2006) Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 92:926\u2013932","journal-title":"Heart"},{"key":"1842_CR23","first-page":"1273","volume":"32","author":"JE Pope","year":"2005","unstructured":"Pope JE, Lee P, Baron M, Dunne J, Smith D, Docherty PS et al (2005) Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 32:1273\u20131278","journal-title":"J Rheumatol"},{"key":"1842_CR24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.62.8.728","volume":"62","author":"CL Hill","year":"2003","unstructured":"Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 62:728\u2013731","journal-title":"Ann Rheum Dis"},{"key":"1842_CR25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/ard.52.7.531","volume":"52","author":"AK Rosenthal","year":"1993","unstructured":"Rosenthal AK, McLaughlin JK, Linet MS, Persson I (1993) Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 52:531\u2013533","journal-title":"Ann Rheum Dis"},{"key":"1842_CR26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/art.22696","volume":"56","author":"NS Goh","year":"2007","unstructured":"Goh NS, Veeraraghavan S, Desai SR, Cramer D, Hansell DM, Denton CP (2007) Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum 56:2005\u20132012","journal-title":"Arthritis Rheum"},{"key":"1842_CR27","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE et al (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655\u20132666","journal-title":"N Engl J Med"},{"key":"1842_CR28","first-page":"2454","volume":"28","author":"S Jacobsen","year":"2001","unstructured":"Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P (2001) Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol 28:2454\u20132459","journal-title":"J Rheumatol"},{"key":"1842_CR29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1378\/chest.08-0053","volume":"134","author":"A Fischer","year":"2008","unstructured":"Fischer A, Swigris JJ, Groshong SD, Cool SD, Sahin H, Lynch DA (2008) Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features and survival. Chest 134:601\u2013605","journal-title":"Chest"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1842-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-1842-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1842-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:18:51Z","timestamp":1559042331000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-1842-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,5]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-1842-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,5]]}}}